U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 474

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr15:60120659-102461201
GRCh38:
Chr15:59828460-101920998
AAGAB, ABHD17C, ABHD2, ACAN, ACSBG1, ADAMTS17, ADAMTS7, ADAMTSL3, ADPGK, ADPGK-AS1, AEN, AGBL1, AGBL1-AS1, AKAP13, ALDH1A3, ALDH1A3-AS1, ALPK3, ANKDD1A, ANKRD34C, ANKRD34C-AS1, ANP32A, ANP32A-IT1, ANPEP, ANXA2, AP3B2, AP3S2, APH1B, ARID3B, ARIH1, ARNT2, ARNT2-DT, ARPIN, ARPIN-AP3S2, ARRDC4, ASB7, BBS4, BCL2A1, BLM, BNC1, BTBD1, C15orf32, C15orf39, C15orf40, C15orf61, C2CD4A, C2CD4B, CA12, CALML4, CARMAL, CCDC33, CD276, CELF6, CEMIP, CERS3, CERS3-AS1, CFAP161, CHASERR, CHD2, CHRNA3, CHRNA5, CHRNB4, CHSY1, CIAO2A, CIB1, CIB2, CILP, CLK3, CLN6, CLPX, COMMD4, CORO2B, COX5A, CPEB1, CPEB1-AS1, CPLX3, CRABP1, CRAT37, CRTC3, CRTC3-AS1, CSK, CSNK1G1, CSPG4, CT62, CTSH, CTXND1, CYP11A1, CYP1A1, CYP1A2, DAPK2, DENND4A, DET1, DIS3L, DIS3L-AS1, DNAJA4, DNAJA4-DT, DPP8, DRAIC, EDC3, EFL1, ETFA, EWSAT1, FAH, FAM174B, FAM219B, FANCI, FBXL22, FBXO22, FBXO22-AS1, FEM1B, FES, FOXB1, FSD2, FURIN, GCAWKR, GDPGP1, GLCE, GOLGA6A, GOLGA6B, GOLGA6C, GOLGA6D, GOLGA6L10, GOLGA6L4, GOLGA6L9, GRAMD2A, HACD3, HAPLN3, HCN4, HDDC3, HDGFL3, HERC1, HEXA, HEXA-AS1, HIGD2B, HMG20A, HOMER2, HYKK, ICE2, IDH2, IDH2-DT, IDH3A, IGDCC3, IGDCC4, IGF1R, IL16, IMP3, INSYN1, INSYN1-AS1, INTS14, IQCH, IQCH-AS1, IQGAP1, IRAIN, IREB2, ISG20, ISL2, ISLR, ISLR2, ITGA11, KBTBD13, KIF23, KIF23-AS1, KIF7, KLHL25, LACTB, LARP6, LCTL, LETR1, LINC00052, LINC00593, LINC00597, LINC00923, LINC00924, LINC00927, LINC00928, LINC00930, LINC00933, LINC01169, LINC01418, LINC01579, LINC01580, LINC01581, LINC01582, LINC01583, LINC01584, LINC01585, LINC01586, LINC02204, LINC02205, LINC02207, LINC02244, LINC02251, LINC02253, LINC02254, LINC02255, LINC02259, LINC02348, LINC02349, LINC02351, LINC02568, LINC02883, LINGO1, LINGO1-AS1, LINGO1-AS2, LINS1, LMAN1L, LOC100128979, LOC100129540, LOC100507472, LOC101927310, LOC101928988, LOC101929439, LOC101929457, LOC101929586, LOC102723335, LOC102724034, LOC102724452, LOC103171574, LOC104613533, LOC105369212, LOC105370954, LOC105370980, LOC105371031, LOC107984784, LOC107988046, LOC107992387, LOC108251791, LOC108281191, LOC108964933, LOC110120860, LOC110120861, LOC110120917, LOC110121345, LOC110121383, LOC110121430, LOC110121464, LOC110121491, LOC110121492, LOC110467515, LOC110467516, LOC110467517, LOC111365216, LOC111413015, LOC111413032, LOC111413043, LOC111562369, LOC111718493, LOC111822949, LOC112272574, LOC112272602, LOC112272603, LOC112272604, LOC112272605, LOC112272606, LOC112272607, LOC112272608, LOC112272609, LOC112272610, LOC112272613, LOC112272614, LOC112272615, LOC112272616, LOC112272617, LOC112272618, LOC112272619, LOC112272620, LOC112272621, LOC112272622, LOC112272623, LOC112296173, LOC112296174, LOC112296175, LOC112296176, LOC112296177, LOC112296178, LOC113939942, LOC113939945, LOC113939946, LOC113939947, LOC114827858, LOC116268467, LOC116268468, LOC116268469, LOC116268470, LOC116268471, LOC116268472, LOC116268473, LOC116268474, LOC116268475, LOC116268476, LOC116268477, LOC116268478, LOC116268479, LOC117204000, LOC117204001, LOC120285840, LOC121530585, LOC121530586, LOC121530587, LOC121530588, LOC121530589, LOC121530590, LOC121530591, LOC121530592, LOC121530593, LOC121530594, LOC121530595, LOC121530596, LOC121530597, LOC121530598, LOC121530599, LOC121530600, LOC121530601, LOC121530602, LOC121530603, LOC121530604, LOC121530605, LOC121847953, LOC121847954, LOC121847955, LOC121847956, LOC121847957, LOC121847958, LOC121847959, LOC121847960, LOC121847961, LOC121847962, LOC121847963, LOC121847964, LOC121847965, LOC121847966, LOC125078089, LOC125078090, LOC125078091, LOC125078093, LOC125078094, LOC125078095, LOC125078096, LOC125078097, LOC125078098, LOC125078099, LOC125078100, LOC125078101, LOC125078102, LOC125078103, LOC125078104, LOC125110343, LOC125110344, LOC125110345, LOC125110346, LOC125110347, LOC125110348, LOC125110349, LOC125110350, LOC125110351, LOC125110352, LOC125110353, LOC125110354, LOC125110355, LOC125110356, LOC125110357, LOC125138289, LOC125138290, LOC125138291, LOC125138292, LOC125138293, LOC125138294, LOC125138295, LOC125138296, LOC125138297, LOC125138298, LOC125138299, LOC125138300, LOC125138301, LOC125138302, LOC125138303, LOC125138305, LOC125138306, LOC125138307, LOC125138308, LOC125138309, LOC125146351, LOC125146353, LOC125146354, LOC125146355, LOC125146356, LOC125146357, LOC125146359, LOC125146360, LOC125146361, LOC125146362, LOC125146363, LOC125146364, LOC125146365, LOC125146367, LOC125146368, LOC125146369, LOC125146370, LOC126862143, LOC126862144, LOC126862145, LOC126862146, LOC126862147, LOC126862148, LOC126862149, LOC126862150, LOC126862151, LOC126862152, LOC126862153, LOC126862154, LOC126862155, LOC126862156, LOC126862157, LOC126862158, LOC126862159, LOC126862160, LOC126862161, LOC126862162, LOC126862163, LOC126862164, LOC126862165, LOC126862166, LOC126862167, LOC126862168, LOC126862169, LOC126862170, LOC126862171, LOC126862172, LOC126862173, LOC126862174, LOC126862175, LOC126862176, LOC126862177, LOC126862178, LOC126862179, LOC126862180, LOC126862181, LOC126862182, LOC126862183, LOC126862184, LOC126862185, LOC126862186, LOC126862187, LOC126862188, LOC126862189, LOC126862190, LOC126862191, LOC126862192, LOC126862193, LOC126862194, LOC126862195, LOC126862196, LOC126862197, LOC126862198, LOC126862199, LOC126862200, LOC126862201, LOC126862202, LOC126862203, LOC126862204, LOC126862205, LOC126862206, LOC126862207, LOC126862208, LOC126862209, LOC126862210, LOC126862211, LOC126862212, LOC126862213, LOC126862214, LOC126862215, LOC126862216, LOC126862217, LOC126862218, LOC126862219, LOC126862220, LOC126862221, LOC126862222, LOC126862223, LOC126862224, LOC126862225, LOC126862226, LOC126862227, LOC126862228, LOC126862229, LOC126862230, LOC126862231, LOC126862232, LOC126862233, LOC126862234, LOC126862235, LOC126862236, LOC126862237, LOC126862238, LOC126862239, LOC126862240, LOC126862241, LOC126862242, LOC126862243, LOC126862244, LOC126862245, LOC126862246, LOC126862247, LOC126862248, LOC126862249, LOC126862250, LOC126862251, LOC126862252, LOC126862253, LOC126862254, LOC126862255, LOC126862256, LOC126862257, LOC126862258, LOC126862259, LOC128071545, LOC283731, LOC91450, LOXL1, LOXL1-AS1, LRRC28, LRRC49, LRRK1, LUNAR1, LYSMD4, MAN2A2, MAN2C1, MAP2K1, MAP2K5, MCTP2, MEF2A, MEGF11, MESD, MESP1, MESP2, MEX3B, MFGE8, MGC15885, MINAR1, MIR11181, MIR1179, MIR12135, MIR1272, MIR1276, MIR1469, MIR184, MIR190A, MIR3174, MIR3175, MIR3529, MIR3713, MIR422A, MIR4311, MIR4312, MIR4313, MIR4511, MIR4512, MIR4513, MIR4514, MIR4515, MIR4714, MIR5009, MIR5094, MIR548AP, MIR549A, MIR5572, MIR6085, MIR629, MIR630, MIR631, MIR6766, MIR6881, MIR6882, MIR7-2, MIR7706, MIR8067, MIR9-3, MIR9-3HG, MORF4L1, MPI, MRPL46, MRPS11, MTFMT, MTHFS, MYO9A, NEIL1, NEO1, NGRN, NMB, NOX5, NPTN, NPTN-IT1, NR2E3, NR2F2, NR2F2-AS1, NRG4, NTRK3, NTRK3-AS1, OAZ2, ODF3L1, OR4F15, OR4F6, PAQR5, PAQR5-DT, PARP16, PARP6, PCAT29, PCLAF, PCSK6, PCSK6-AS1, PDCD7, PDE8A, PEAK1, PEX11A, PGPEP1L, PIAS1, PIF1, PIRC76, PKM, PLEKHO2, PLIN1, PML, POLG, POLGARF, PPCDC, PPIB, PRC1, PRC1-AS1, PSMA4, PSTPIP1, PTPN9, RAB11A, RAB8B, RAMAC, RASGRF1, RASL12, RBPMS2, RCCD1, RCCD1-AS1, RCN2, REC114, RGMA, RHCG, RLBP1, RNU5A-1, RNU5B-1, RNU6-1, RORA, RORA-AS1, RORA-AS2, RPL4, RPLP1, RPP25, RPS17, RPS27L, SALRNA2, SALRNA3, SAXO2, SCAMP2, SCAMP5, SCAPER, SCARNA14, SCARNA15, SEC11A, SELENOS, SEMA4B, SEMA7A, SENP8, SH2D7, SH3GL3, SLC51B, SIN3A, SKIC8, SKOR1, SKOR1-AS1, SLC24A1, SLC28A1, SLCO3A1, SMAD3, SMAD3-DT, SMAD6, SMASR, SNAPC5, SNHG21, SNORA24B, SNORD13E, SNORD16, SNORD18A, SNORD18B, SNORD18C, SNRPA1, SNRPA1-DT, SNUPN, SNX1, SNX22, SNX33, SPATA41, SPATA8, SPATA8-AS1, SPESP1, SPG21, ST20, ST20-AS1, ST20-MTHFS, ST8SIA2, STARD5, STOML1, STRA6, SV2B, SYNM, SYNM-AS1, TARS3, TBC1D21, TBC1D2B, THAP10, THSD4, THSD4-AS1, THSD4-AS2, TICRR, TIPIN, TLE3, TLN2, TLNRD1, TM2D3, TM6SF1, TMC3, TMC3-AS1, TMED3, TMEM202, TMEM202-AS1, TMEM266, TPM1, TPM1-AS, TRC-GCA5-1, TRIP4, TRK-CTT1-2, TRQ-CTG1-4, TRR-TCG1-1, TSPAN3, TTC23, TTLL13, UACA, UBAP1L, UBE2Q2, UBL7, UBL7-DT, ULK3, UNC45A, USP3, USP3-AS1, VPS13C, VPS13C-DT, VPS33B, VPS33B-DT, WDR73, WDR93, WHAMM, ZFAND6, ZNF592, ZNF609, ZNF710, ZNF710-AS1, ZNF774, ZSCAN2, ZWILCH
See casesPathogenic
(Oct 24, 2012)
no assertion criteria provided
2.
GRCh37:
Chr15:66678919
GRCh38:
Chr15:66386581
MAP2K1, TIPINnot providedBenign
(Jun 19, 2018)
criteria provided, single submitter
3.
GRCh37:
Chr15:66678991
GRCh38:
Chr15:66386653
MAP2K1, TIPINnot providedBenign
(Jun 14, 2018)
criteria provided, single submitter
4.
GRCh37:
Chr15:66679055
GRCh38:
Chr15:66386717
TIPIN, MAP2K1not providedBenign
(Jun 14, 2018)
criteria provided, single submitter
5.
GRCh37:
Chr15:66679139
GRCh38:
Chr15:66386801
MAP2K1not providedLikely benign
(Jun 16, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr15:66679238
GRCh38:
Chr15:66386900
MAP2K1not providedLikely benign
(Jul 31, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr15:66679464-66679465
GRCh38:
Chr15:66387126-66387127
MAP2K1not provided, Cardio-facio-cutaneous syndrome, Noonan syndrome
Likely benign
(Oct 16, 2018)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr15:66679574-66679575
GRCh38:
Chr15:66387236-66387237
MAP2K1not providedLikely benign
(Nov 15, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr15:66679601
GRCh38:
Chr15:66387263
MAP2K1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
10.
GRCh37:
Chr15:66679643
GRCh38:
Chr15:66387305
MAP2K1not providedLikely benign
(Feb 7, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr15:66679649-66679650
GRCh38:
Chr15:66387311-66387312
MAP2K1not specifiedBenign
(Apr 15, 2014)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr15:66679684
GRCh38:
Chr15:66387346
MAP2K1Cardiovascular phenotype, Noonan syndrome and Noonan-related syndrome, not specified,
not provided, RASopathy
Benign
(Jul 7, 2021)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr15:66679690
GRCh38:
Chr15:66387352
MAP2K1P2RRASopathyUncertain significance
(May 17, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr15:66679691
GRCh38:
Chr15:66387353
MAP2K1RASopathyLikely benign
(Apr 24, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr15:66679691
GRCh38:
Chr15:66387353
MAP2K1Cardiovascular phenotype, Noonan syndrome and Noonan-related syndrome, not specified,
not provided, RASopathy
Benign/Likely benign
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr15:66679696
GRCh38:
Chr15:66387358
MAP2K1K4Rnot providedUncertain significance
(Mar 27, 2017)
criteria provided, single submitter
17.
GRCh37:
Chr15:66679697
GRCh38:
Chr15:66387359
MAP2K1RASopathy, Cardiovascular phenotypeLikely benign
(Sep 18, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr15:66679700
GRCh38:
Chr15:66387362
MAP2K1not specified, RASopathyLikely benign
(May 28, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr15:66679714
GRCh38:
Chr15:66387376
MAP2K1Q10Lnot specifiedUncertain significance
(Aug 12, 2019)
criteria provided, single submitter
20.
GRCh37:
Chr15:66679718
GRCh38:
Chr15:66387380
MAP2K1RASopathyLikely benign
(Jul 14, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr15:66679721
GRCh38:
Chr15:66387383
MAP2K1not providedLikely benign
(Jun 25, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr15:66679722
GRCh38:
Chr15:66387384
MAP2K1P13Snot providedUncertain significance
(Sep 20, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr15:66679724
GRCh38:
Chr15:66387386
MAP2K1RASopathy, not specifiedLikely benign
(Apr 7, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr15:66679726
GRCh38:
Chr15:66387388
MAP2K1D16fsnot providedUncertain significance
(Sep 16, 2018)
no assertion criteria provided
25.
GRCh37:
Chr15:66679727
GRCh38:
Chr15:66387389
MAP2K1not providedUncertain significance
(Dec 19, 2019)
criteria provided, single submitter
26.
GRCh37:
Chr15:66679728
GRCh38:
Chr15:66387390
MAP2K1P15ACardiovascular phenotypeUncertain significance
(May 15, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr15:66679728
GRCh38:
Chr15:66387390
MAP2K1P15SRASopathyUncertain significance
(Aug 19, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr15:66679730
GRCh38:
Chr15:66387392
MAP2K1Cardiovascular phenotypeLikely benign
(Oct 17, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr15:66679733
GRCh38:
Chr15:66387395
MAP2K1D16ERASopathyUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
30.
GRCh37:
Chr15:66679738
GRCh38:
Chr15:66387400
MAP2K1S18Cnot providedUncertain significance
(Jan 1, 2019)
criteria provided, single submitter
31.
GRCh37:
Chr15:66679741
GRCh38:
Chr15:66387403
MAP2K1A19Gnot specified, RASopathyUncertain significance
(Mar 5, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr15:66679754
GRCh38:
Chr15:66387416
MAP2K1RASopathyLikely benign
(May 9, 2017)
reviewed by expert panel
FDA Recognized Database
33.
GRCh37:
Chr15:66679755
GRCh38:
Chr15:66387417
MAP2K1S24GRASopathyUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
34.
GRCh37:
Chr15:66679756
GRCh38:
Chr15:66387418
MAP2K1S24TRASopathyUncertain significance
(Aug 20, 2021)
criteria provided, single submitter
35.
GRCh37:
Chr15:66679761
GRCh38:
Chr15:66387423
MAP2K1A26Tnot providedUncertain significance
(Oct 15, 2020)
criteria provided, single submitter
36.
GRCh37:
Chr15:66679762
GRCh38:
Chr15:66387424
MAP2K1A26VRASopathyUncertain significance
(Oct 22, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr15:66679774
GRCh38:
Chr15:66387436
MAP2K1RASopathyLikely benign
(Jun 4, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr15:66679779
GRCh38:
Chr15:66387441
MAP2K1not providedLikely benign
(Apr 22, 2016)
criteria provided, single submitter
39.
GRCh37:
Chr15:66679781
GRCh38:
Chr15:66387443
MAP2K1RASopathyLikely benign
(Aug 9, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr15:66679783-66679784
GRCh38:
Chr15:66387445-66387446
MAP2K1RASopathyLikely benign
(Oct 10, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr15:66679793
GRCh38:
Chr15:66387455
MAP2K1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
42.
GRCh37:
Chr15:66679798
GRCh38:
Chr15:66387460
MAP2K1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
43.
GRCh37:
Chr15:66679798
GRCh38:
Chr15:66387460
MAP2K1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
44.
GRCh37:
Chr15:66679819
GRCh38:
Chr15:66387481
MAP2K1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
45.
GRCh37:
Chr15:66679850
GRCh38:
Chr15:66387512
MAP2K1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
46.
GRCh37:
Chr15:66679851
GRCh38:
Chr15:66387513
MAP2K1not providedBenign
(Jun 6, 2019)
criteria provided, single submitter
47.
GRCh37:
Chr15:66679958
GRCh38:
Chr15:66387620
MAP2K1not providedBenign
(Jul 27, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr15:66727345
GRCh38:
Chr15:66435007
MAP2K1RASopathyLikely benign
(Sep 15, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr15:66727352
GRCh38:
Chr15:66435014
MAP2K1RASopathyLikely benign
(Oct 23, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr15:66727370
GRCh38:
Chr15:66435032
MAP2K1N29S, N7SRASopathyUncertain significance
(Feb 18, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr15:66727379
GRCh38:
Chr15:66435041
MAP2K1A10V, A32VCardiovascular phenotypeUncertain significance
(Jul 7, 2021)
criteria provided, single submitter
52.
GRCh37:
Chr15:66727383
GRCh38:
Chr15:66435045
MAP2K1RASopathyLikely benign
(Jun 15, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr15:66727392
GRCh38:
Chr15:66435054
MAP2K1not provided, RASopathyLikely benign
(Sep 11, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr15:66727408
GRCh38:
Chr15:66435070
MAP2K1L42Fnot specified, Cardio-facio-cutaneous syndromeConflicting interpretations of pathogenicity
(Aug 27, 2021)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr15:66727409
GRCh38:
Chr15:66435071
MAP2K1L20R, L42Rnot providedUncertain significance
(May 9, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr15:66727410-66727412
GRCh38:
Chr15:66435072-66435074
MAP2K1D43delRASopathyUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
57.
GRCh37:
Chr15:66727413-66727445
GRCh38:
Chr15:66435075-66435107
MAP2K1RASopathyUncertain significance
(Oct 14, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr15:66727419
GRCh38:
Chr15:66435081
MAP2K1Q45Hnot providedUncertain significance
(Jun 7, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr15:66727421
GRCh38:
Chr15:66435083
MAP2K1Q46LCardio-facio-cutaneous syndromeLikely pathogenicno assertion criteria provided
60.
GRCh37:
Chr15:66727423
GRCh38:
Chr15:66435085
MAP2K1R25*, R47*not providedUncertain significance
(Aug 19, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr15:66727424
GRCh38:
Chr15:66435086
MAP2K1R47Qnot specified, RASopathyUncertain significance
(Jun 12, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr15:66727430
GRCh38:
Chr15:66435092
MAP2K1R27H, R49HRASopathyUncertain significance
(Jun 12, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr15:66727431
GRCh38:
Chr15:66435093
MAP2K1RASopathyLikely benign
(Dec 8, 2020)
criteria provided, single submitter
64.
GRCh37:
Chr15:66727433
GRCh38:
Chr15:66435095
MAP2K1L50Pnot providedPathogenic
(Jan 9, 2020)
criteria provided, single submitter
65.
GRCh37:
Chr15:66727437
GRCh38:
Chr15:66435099
MAP2K1RASopathyLikely benign
(May 20, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr15:66727440
GRCh38:
Chr15:66435102
MAP2K1Cardiovascular phenotype, not specifiedLikely benign
(Mar 16, 2020)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr15:66727440
GRCh38:
Chr15:66435102
MAP2K1not specified, not provided, RASopathy
Benign/Likely benign
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr15:66727441
GRCh38:
Chr15:66435103
MAP2K1F53IGastric adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin,
Lung adenocarcinoma
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
69.
GRCh37:
Chr15:66727441
GRCh38:
Chr15:66435103
MAP2K1F53VGastric adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin,
Lung adenocarcinoma
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
70.
GRCh37:
Chr15:66727441
GRCh38:
Chr15:66435103
MAP2K1F53LMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
71.
GRCh37:
Chr15:66727442
GRCh38:
Chr15:66435104
MAP2K1F53SCardio-facio-cutaneous syndromePathogenic
(May 9, 2017)
reviewed by expert panel
FDA Recognized Database
72.
GRCh37:
Chr15:66727443
GRCh38:
Chr15:66435105
MAP2K1F53LNeoplasm of the large intestine, Gastric adenocarcinoma, Malignant melanoma of skin,
Lung adenocarcinoma
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
73.
GRCh37:
Chr15:66727445
GRCh38:
Chr15:66435107
MAP2K1L54PRASopathyPathogenic
(Dec 24, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr15:66727451
GRCh38:
Chr15:66435113
MAP2K1Q56Pnot providedPathogenic
(Jul 2, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr15:66727453
GRCh38:
Chr15:66435115
MAP2K1K57EMelanoma, MelorheostosisPathogenic/Likely pathogenic
(Jun 23, 2020)
no assertion criteria provided
76.
GRCh37:
Chr15:66727453
GRCh38:
Chr15:66435115
MAP2K1K57QRASopathyLikely pathogenic
(May 9, 2017)
reviewed by expert panel
FDA Recognized Database
77.
GRCh37:
Chr15:66727454
GRCh38:
Chr15:66435116
MAP2K1K35M, K57Mnot providedPathogenic
(Mar 31, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr15:66727454
GRCh38:
Chr15:66435116
MAP2K1K57TProstate adenocarcinoma, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin,
Non-Hodgkin lymphoma, Lung adenocarcinoma, Gastric adenocarcinoma
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
79.
GRCh37:
Chr15:66727455
GRCh38:
Chr15:66435117
MAP2K1K57NProstate adenocarcinoma, Malignant melanoma of skin, Lung adenocarcinoma,
Non-Hodgkin lymphoma, Squamous cell carcinoma of the head and neck, Gastric adenocarcinoma,
Melanoma
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
80.
GRCh37:
Chr15:66727455
GRCh38:
Chr15:66435117
MAP2K1K57Nnot providedPathogenic
(Apr 26, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr15:66727456-66727470
GRCh38:
Chr15:66435118-66435132
MAP2K1Parkes Weber syndromePathogeniccriteria provided, single submitter
82.
GRCh37:
Chr15:66727457-66727459
GRCh38:
Chr15:66435119-66435121
MAP2K1K59delnot provided, RASopathyLikely pathogenic
(Sep 2, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr15:66727458
GRCh38:
Chr15:66435120
MAP2K1Q58HCardiofaciocutaneous syndrome 3Uncertain significanceno assertion criteria provided
84.
GRCh37:
Chr15:66727458-66727472
GRCh38:
Chr15:66435120-66435134
MAP2K1not providedLikely pathogenic
(Mar 8, 2016)
criteria provided, single submitter
85.
GRCh37:
Chr15:66727461
GRCh38:
Chr15:66435123
MAP2K1RASopathy, not specifiedBenign/Likely benign
(Jun 28, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr15:66727463
GRCh38:
Chr15:66435125
MAP2K1V60Gnot providedUncertain significance
(Jul 10, 2012)
criteria provided, single submitter
87.
GRCh37:
Chr15:66727468-66727482
GRCh38:
Chr15:66435130-66435144
MAP2K1not providedLikely pathogenic
(Mar 8, 2016)
criteria provided, single submitter
88.
GRCh37:
Chr15:66727482
GRCh38:
Chr15:66435144
MAP2K1D66ERASopathyUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr15:66727482
GRCh38:
Chr15:66435144
MAP2K1RASopathy, Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype
Conflicting interpretations of pathogenicity
(Sep 15, 2022)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr15:66727483
GRCh38:
Chr15:66435145
MAP2K1D67NCardio-facio-cutaneous syndromePathogenic
(May 9, 2017)
reviewed by expert panel
FDA Recognized Database
91.
GRCh37:
Chr15:66727489
GRCh38:
Chr15:66435151
MAP2K1E69KRASopathyUncertain significance
(Jul 5, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr15:66727496
GRCh38:
Chr15:66435158
MAP2K1I71TRASopathyUncertain significance
(Jul 31, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr15:66727496
GRCh38:
Chr15:66435158
MAP2K1I71SRASopathyUncertain significance
(Mar 18, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr15:66727499
GRCh38:
Chr15:66435161
MAP2K1S50N, S72NRASopathyUncertain significance
(Oct 2, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr15:66727518
GRCh38:
Chr15:66435180
MAP2K1RASopathyLikely benign
(Sep 25, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr15:66727521
GRCh38:
Chr15:66435183
MAP2K1Cardiovascular phenotype, Noonan syndrome and Noonan-related syndrome, not specified,
RASopathy, Noonan syndrome 1, Cardiofaciocutaneous syndrome 3,
Melorheostosis
Benign/Likely benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr15:66727522
GRCh38:
Chr15:66435184
MAP2K1G80SRASopathyUncertain significance
(Sep 17, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr15:66727535
GRCh38:
Chr15:66435197
MAP2K1K84Rnot specified, Noonan syndrome and Noonan-related syndrome, not provided,
RASopathy
Uncertain significance
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr15:66727539
GRCh38:
Chr15:66435201
MAP2K1RASopathyLikely benign
(Dec 14, 2020)
criteria provided, single submitter
100.
GRCh37:
Chr15:66727539
GRCh38:
Chr15:66435201
MAP2K1RASopathy, Cardiovascular phenotypeLikely benign
(Jul 26, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination